Flushing
Information
- Disease name
- Flushing
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00533611 | Completed | Phase 3 | Effect of MK0524A on Flushing Caused by Niacin (0524A-056) | April 2007 | August 2007 |
NCT00533676 | Completed | Phase 2 | Endpoint Validation Study (0524A-015) | August 2004 | December 2006 |
NCT00536237 | Completed | Phase 2 | MK0524A Phase IIb Study (0524A-011)(COMPLETED) | August 2004 | December 2006 |
NCT00895193 | Completed | N/A | Alternative Options to Minimize Niacin-Induced Flushing | January 2009 | December 2010 |
NCT00913081 | Completed | Phase 4 | Advancing Niacin by Inhibiting Flushing (ANTI-FLUSH) | February 2009 | December 2009 |
NCT00930839 | Completed | Role of Prostaglandins on Niacin-Induced Flushing | March 2009 | February 2010 | |
NCT03370848 | Completed | Phase 4 | Effects of Psyllium on Niacin Tolerability | March 2009 | July 2011 |
NCT03497442 | Completed | Early Phase 1 | Treatment of Asian Flushing Syndrome With Topical Alpha Agonists | July 12, 2018 | March 25, 2019 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0031284
- ICD10 preferred id (Insert disease from ICD10)
- D0015022
- ICD10 class code (Insert disease from ICD10)
- R23.2
- MeSH unique ID (MeSH (Medical Subject Headings))
- D005483